September 25, 2023 Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes Amanda Klein, Alexandre Loupy, Mark Stegall, Ilkka Helanterä, Luke Kosinski, Eric Frey, Olivier Aubert, Gillian Divard, Kenneth N
August 3, 2018 Quantitative Approach for Cardiac Risk Assessment and Interpretation in Tuberculosis Drug Development
June 9, 2018 Literature review to assemble the evidence for response scales used in patient-reported outcome measures
June 9, 2018 Literature review to characterize the empirical basis for response scale selection in pediatric populations
January 9, 2018 Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis
January 9, 2018 Training on the use of technology to collect patient-reported outcome data electronically in clinical trials: best practice recommendations from the ePRO Consortium Ly, JJ, Crescioni, M, Eremenco, S, Bodart, S, Donoso, M, Butler, AJ, et al. Training on the use of technology to collect patient-r
January 6, 2018 Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO Consortium
January 6, 2018 Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop